A 783-patient phase III trial found more heartburn-free days with tegoprazan than placebo in non-erosive reflux disease; FDA review status is unclear.
Fast-Acting Pill Reduces Heartburn Frequency In Non-Erosive Reflux Disease
Browsing Category
Health & Sleep
588 posts
People Who Walk More Each Day Tend To Score Better On Several Brain Tests
A U.S. study linked higher daily step counts with better scores on three cognitive tasks, but its one-time testing cannot show cause and effect.
Rampant Inflammation In Heart Failure: Can Anything Be Done About It?
A POSEIDON analysis found hsCRP of at least 2 mg/L in about half of U.S. heart failure participants, while targeted anti-inflammatory treatment remains unsettled.
Want More Joy In Retirement? Look At How You Spent Last Week
A Sixty and Me contributor suggests reviewing last week’s activities to identify what brings joy and what crowds it out in retirement.
Oral Peptide Shows Durable Efficacy In Ulcerative Colitis
In a phase IIb extension, most continuing icotrokinra patients had clinical response, remission or endoscopic improvement at week 76; phase III testing is underway.
Scientists Discover A Surprising Paradox In How Our Cells Age
A study of blood, skin and neuron-like cells found autophagy can rise, fall or stay stable with age, depending on cell type and sex.
Antioxidant May Influence Brain Changes In Multiple Sclerosis, Study Suggests
A 36-person randomized trial linked N-acetylcysteine treatment to brain imaging changes and self-reported symptom improvements in multiple sclerosis.
AI Has A Darker Side In Healthcare, Expert Says
At a health journalism summit, researchers warned AI may erode clinical skills, increase worker monitoring and change pay and job conditions.
The Gift I Never Expected But Came To Love Anyway
A Sixty and Me personal essay recounts how a large wind chime, initially unwanted, became a comforting part of a couple’s new Arizona home.
Mystery Surrounds Young Worker’s Death At Russia Lab Studying Severe Diseases
The WHO says the cause of a young worker’s death at a Russian disease research lab remains unknown after Russian officials reported more than 5,500 tests.
